All posts tagged
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
More News! Trump targets Pharma, €1B Deal for Ipsen, & a Hep B update
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Allergan signs massive €3Bn Alzheimer deal
In the end, Pfizer will NOT become an Irish Company #noguinnessforpfizer
Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!
Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!
Pfizer & Allergan €140Bn Merger: Is the Biggest Deal in Pharma Actually Going to Happen?
To beat J&J, Pfizer attempts a New Merger…Guess who’s the Target this Time?!
Roche’s patent halts an Amgen biosimilar debut
Labiotech UG, All Rights Reserved -
Send this to friend